Coty Inc. is a global beauty company that specializes in the development, manufacturing, and marketing of a wide range of beauty products, including perfumes, cosmetics, and skincare solutions
With a diverse portfolio that includes both established and emerging brands, Coty aims to enhance the beauty experience for consumers through innovative and high-quality offerings. The company focuses on creating iconic fragrances, cutting-edge makeup products, and luxurious skincare treatments, catering to a variety of customer preferences and market segments. Through its commitment to sustainability and social responsibility, Coty continues to evolve its product lines and business practices to meet the changing needs of consumers around the world.
Coty (NYSE: COTY) (Paris: COTY), one of the world’s largest beauty companies, with an iconic portfolio of brands across fragrance, color cosmetics, skin and body care, hosted a cross-industry roundtable to discuss restrictive beauty ideals and definitions. As the next chapter of the award-winning #UndefineBeauty campaign, the panel debunks beauty myths and includes perspectives on neuroscience, art, social media, sociology, and mental health, and underscores the need for collective action to drive change.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including BeautyHealth (NASDAQ:SKIN) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Coty (NYSE:COTY) and its peers.
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums).
That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
Stifel analyst Mark S. Astrachan lowered Coty's price target from $8.5 to $8, maintaining a Hold rating. Despite adjusted EBITDA growth, Coty's second-quarter FY25 results revealed a 1% YoY decline in net revenue and a challenging outlook for the second half of FY25.
Beauty products company Coty (NYSE:COTY) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 3.3% year on year to $1.67 billion. Its non-GAAP profit of $0.11 per share was 47.7% below analysts’ consensus estimates.
What a brutal six months it’s been for Coty. The stock has dropped 31.4% and now trades at $6.83, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. On the other hand, they usually underperform during bull runs,
but the sector has bucked this trend lately as its six-month return of 6.9% has closely followed the S&P 500.
Coty (NYSE: COTY) (Paris: COTY), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care, has joined forces with world-renowned crystal house Swarovski to announce an agreement for a long-term beauty license, with the opportunity to develop, produce and distribute a new vision of fragrances.
